SCHEMBL564953

SCHEMBL564953

CC(C)CN(Cc1cc(Cl)c2c(c1)OCCCO2)C(=O)C(C)CN(C)c1cccnc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PROKR2 Q8NFJ6 5/20 0.54
PDK1 Q15118 2/20 0.34
MAPK8 P45983 1/20 0.33
NAMPT P43490 1/20 0.33
CTNNB1 P35222 1/20 0.33
WNT3A P56704 1/20 0.33
LMNA P02545 1/20 0.33
ALDH1A1 P00352 3/20 0.33
GAA P10253 2/20 0.33
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 1/20 0.33
GLA P06280 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TP53 P04637 1/20 0.32
PTGES O14684 1/20 0.32
AKR1C3 P42330 1/20 0.32
FNTA P49354 1/20 0.32
FNTB P49356 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL564150 0.90 PROKR2 (0.54) PROKR2PDK1MAPK8CTNNB1WNT3A
SCHEMBL565001 0.84 PROKR2 (0.56) PROKR2MAPK8GAA
SCHEMBL565671 0.84 PROKR2 (0.52) PROKR2MAPK8
SCHEMBL564954 0.84 PROKR2 (0.66) PROKR2NAMPTLMNAALDH1A1GAA
SCHEMBL564204 0.83 PROKR2 (0.56) PROKR2MAPK8CTNNB1WNT3AALDH1A1
SCHEMBL564857 0.82 PROKR2 (0.54) PROKR2MAPK8CTNNB1WNT3AALDH1A1
SCHEMBL565424 0.81 PROKR2 (0.53) PROKR2MAPK8ALDH1A1
SCHEMBL565624 0.81 PROKR2 (0.56) PROKR2MAPK8LMNAALDH1A1GAA
SCHEMBL565620 0.80 PROKR2 (0.55) PROKR2MAPK8ALDH1A1
SCHEMBL565182 0.80 PROKR2 (0.54) PROKR2MAPK8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof PROKR2, PROKR1, GIPR PROKR2 1/4885PDK1 1308/4885MAPK8 1270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.